98434-34-5

Basic information

• Product Name: 3-METHOXY-2-NITRO-4-HYDROXY-5-BROMO-BENZALDEHYDE
• Synonyms: 3-METHOXY-2-NITRO-4-HYDROXY-5-BROMO-BENZALDEHYDE;5-bromo-4-hydroxy-3-methoxy-2-nitro-benzaldehyde
• CAS NO: 98434-34-5
• Molecular Formula: C₈H₆BrNO₅
• Molecular Weight: 276.0409
• Mol File: 98434-34-5.mol
• Article Data: 3

Chemical Properties

• Boiling Point: 377.6°Cat760mmHg
• Flash Point: 182.2°C
• Appearance: /
• Density: 1.821g/cm³
• Vapor Pressure: 3.07E-06mmHg at 25°C
• Refractive Index: 1.657
• CAS DataBase Reference: 3-METHOXY-2-NITRO-4-HYDROXY-5-BROMO-BENZALDEHYDE(CAS DataBase Reference)
• NIST Chemistry Reference: 3-METHOXY-2-NITRO-4-HYDROXY-5-BROMO-BENZALDEHYDE(98434-34-5)
• EPA Substance Registry System: 3-METHOXY-2-NITRO-4-HYDROXY-5-BROMO-BENZALDEHYDE(98434-34-5)

Safety Data

• Hazardous Substances Data: 98434-34-5(Hazardous Substances Data)

Usage

InChI:InChI=1/C8H6BrNO5/c1-15-8-6(10(13)14)4(3-11)2-5(9)7(8)12/h2-3,12H,1H3

Upstream product

• 2450-26-2 2-nitrovanillin 
• 2698-69-3 4-formyl-2-methoxy-3-nitrophenyl acetate 
• 881-68-5 vanillin acetate 

Downstream Products

• 1001433-40-4 C₇H₄BrNO₅ 
• 1415470-15-3 (2S,3R,4R,5S,6R)-2-(7-chloro-6-(4-cyclopropylbenzyl)benzo[d][1,3]dioxol-4-yl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol 
• 1346753-51-2 C₂₄H₁₇BrCl₂N₄O₇ 
• 873973-33-2 5-bromo-2-nitroveratraldehyde 
• 161617-42-1 2-amino-5-bromo-4-hydroxy-3-methoxybenzaldehyde 

Relevant articles and documents

METHOD FOR PREPARING DIPHENYLMETHANE DERIVATIVES

The present invention relates to an improved process for preparing a diphenyl methane derivative which is useful as an inhibitor of a sodium-dependent glucose transporter (SGLT). Since the process of the present invention is performed by convergent synthe

Synthesis of 1,2,3,9-tetrahydro-7-bromo-6-hydroxy-5-methoxypyrrolo-[2,1-b]- quinazol ine: A new analog of deoxyvasicine

A new deoxyvasicine analog (9) was synthesized by condensation of 2-amino-5-bromovanillin (6) with 4-aminobutyraldehyde (7) in phosphate buffer (pH 5.8) followed by hydrogenation of the resulting quinazolinium complex (8) at 65°C in presence of 5% palladium-on-barium sulfate.